Abrupt Discontinuation of Long-Term Opioid Therapies Among Privately Insured or Medicare Advantage Adults, 2011-2017

Pain Med. 2021 Jul 25;22(7):1702-1704. doi: 10.1093/pm/pnaa350.

Authors

Yuhua Bao^{1

2}, Katherine Wen³, Phyllis Johnson¹, Lisa R Witkin⁴, M Carrington Reid⁵

Affiliations

¹ Department of Healthcare Policy & Research, Weill Cornell Medicine, New York, New York, USA.
² Department of Psychiatry, Weill Cornell Medicine, New York, New York, USA.
³ Department of Policy Analysis & Management, Cornell University, Ithaca, New York, USA.
⁴ Division of Pain Management, Department of Anesthesiology, Weill Cornell Medicine, New York, New York, USA.
⁵ Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Analgesics, Opioid* / therapeutic use
Humans
Insurance, Health
Medicare Part C*
Retrospective Studies
United States

Substances

Analgesics, Opioid

Grants and funding